Volume | 1 |
|
|||||
News | - | ||||||
Day High | 0.2475 | Low High |
|||||
Day Low | 0.2475 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Oncology Institute Inc | TOIIW | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.2475 | 0.2475 | 0.2475 | 0.2475 | 0.2255 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
2 | 1 | - | 0.022 - 0.3699 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:28:08 | 1 | $ 0.2475 | USD |
Oncology Institute Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
809.76M | 73.75M | - | 324.24M | -83.07M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oncology Institute News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOIIW Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.2255 | 0.2475 | 0.182 | 0.2255 | 68 | 0.022 | 9.76% |
1 Month | 0.2135 | 0.2475 | 0.155 | 0.2004361 | 12,807 | 0.034 | 15.93% |
3 Months | 0.23 | 0.3699 | 0.155 | 0.2358141 | 9,468 | 0.0175 | 7.61% |
6 Months | 0.07 | 0.3699 | 0.065 | 0.2057391 | 6,788 | 0.1775 | 253.57% |
1 Year | 0.061 | 0.3699 | 0.022 | 0.0959374 | 11,150 | 0.1865 | 305.74% |
3 Years | 1.775 | 1.775 | 0.022 | 0.5474566 | 17,714 | -1.53 | -86.06% |
5 Years | 1.775 | 1.775 | 0.022 | 0.5474566 | 17,714 | -1.53 | -86.06% |
Oncology Institute Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |